CTMX
CytomX Therapeutics Inc
2.70$
-0.4%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
CytomX Therapeutics Inc (CTMX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -76 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32 | -27 | -2.0 | 170 | -76 | -140 | 5.3 | -119 | -111 | -56 | -86 | -76 | |
| 0.8 | 1.2 | 1.7 | 1.6 | 1.9 | 2.6 | 2.6 | 2.7 | 2.4 | 2.2 | 1.8 | 1.4 | |
| 0.6 | 4.0 | 10 | 11 | 17 | 19 | 15 | 13 | 13 | 8.6 | 7.7 | 6.3 | |
| 0.6 | 6.9 | 12 | 22 | 17 | 21 | 15 | 13 | 13 | – | – | – | |
| 61 | -0.2 | 43 | 190 | -8.0 | -31 | 18 | -55 | -31 | -63 | -126 | -69 | |
| 1.7 | 1.6 | 2.2 | 1.6 | 3.8 | 3.5 | 2.3 | 1.6 | 1.7 | 0.8 | 0.3 | 0.2 | |
| -1.7 | -131 | 46 | -121 | 5.9 | 80 | -19 | 22 | 98 | -151 | 100 | -60 | |
| – | 6.7 | 0.0 | 0.0 | – | – | – | – | – | – | – | 3.0 | |
| 0.0 | 6.7 | 0.9 | 24 | 140 | 1.6 | 17 | 110 | 110 | – | – | – | |
| -1.3 | -3.1 | 0.1 | – | – | – | – | – | – | – | – | – | |
| 26 | 153 | 1.0 | 24 | 140 | 1.6 | 17 | 110 | 0.6 | 30 | 7.5 | 110 | |
| 56 | -4.6 | 45 | 73 | 70 | -59 | 3.4 | 14 | -12 | -176 | 21 | -25 | |
| 30 | -29 | -4.2 | 169 | -79 | -144 | 3.0 | -121 | -113 | -57 | -87 | -76 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.